Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia

Blood

Volumn 120, Issue 22, 2012, Pages 4441-4443

  Eyre, Toby ^a,b   Schwab, Claire J ^c   Kinstrie, Ross ^d   McGuire, Ann Keen ^a   Strefford, Jen ^a   Peniket, Andrew ^a   Mead, Adam ^a,b   Littlewood, Tim ^a   Holyoake, Tessa L ^d   Copland, Mhairi ^d   Moorman, Anthony V ^c   Harrison, Christine J ^c   Vyas, Paresh ^a,b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; DAUNORUBICIN; HEMOGLOBIN; PREDNISOLONE; VINCRISTINE;

ABL1 NUP214 FUSION GENE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; B CELL LEUKEMIA; BLAST CELL; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME DUPLICATION; CHROMOSOME REARRANGEMENT; EPISOME; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE AMPLIFICATION; GENE DELETION; HUMAN; LETTER; LEUKEMIA REMISSION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

EID: 84869761099     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-456517     Document Type: Letter

References (9)

1. Graux C, Cools J, Melotte C, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004;36(10):1084-1089. (Pubitemid 41184470)
2. Graux C, Stevens-Kroef M, Lafage M, et al. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia. 2009;23(1):125-133.
3. Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22(2):153-166.
4. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446(7137):758-764. (Pubitemid 46582031)
5. Parker H, An Q, Barber K, et al. The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. Genes Chromosomes Cancer. 2008;47(12):1118-1125.
6. Loudin MG, Wang J, Leung HC, et al. Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia. 2011;25(10):1555-1563.
7. De Keersmaecker K, Versele M, Cools J, Superti-Furga G, Hantschel O. Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases. Leukemia. 2008;22(12):2208- 2216.
8. Deenik W, Beverloo HB, van der Poel-van de Luytgaarde SC, et al. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia. Leukemia. 2009;23(3):627-629.
9. Clarke S, O'Reilly J, Romeo G, Cooney J. NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse. Leuk Res. 2011;35(7):e131-e133.